Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
711 - Can patient survey data from CADTH be used for an unbranded tool on current patient experience and behaviour?
-
CADTH is an important tool for explaining recommendations for funding decisions, but it is not designed or intended to support product claims in drug advertising. See AskPAAB question 541 for more information on this topic. For claims related to patient experience and behaviour which do not relate to pharmacotherapy (i.e. disease attitude and opinions), then we may consider surveys as a source depending on the design, and execution of the survey. However, the primary source to support these claims should be the survey itself, not the CADTH document.
